Prevention of diabetic nephropathy

Barry J Materson, Richard A Preston

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Normalization of blood pressure-and use of an ACE inhibitor or AT 1- receptor blocker for patients with abnormal albumin or creatinine levels-can prevent or significantly slow the rate of progression toward end-stage renal disease.

Original languageEnglish
Pages (from-to)129-140
Number of pages12
JournalHospital Practice
Volume32
Issue number2
StatePublished - Feb 15 1997

Fingerprint

Diabetic Nephropathies
Angiotensin-Converting Enzyme Inhibitors
Chronic Kidney Failure
Albumins
Creatinine
Blood Pressure

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prevention of diabetic nephropathy. / Materson, Barry J; Preston, Richard A.

In: Hospital Practice, Vol. 32, No. 2, 15.02.1997, p. 129-140.

Research output: Contribution to journalArticle

Materson, BJ & Preston, RA 1997, 'Prevention of diabetic nephropathy', Hospital Practice, vol. 32, no. 2, pp. 129-140.
Materson BJ, Preston RA. Prevention of diabetic nephropathy. Hospital Practice. 1997 Feb 15;32(2):129-140.
Materson, Barry J ; Preston, Richard A. / Prevention of diabetic nephropathy. In: Hospital Practice. 1997 ; Vol. 32, No. 2. pp. 129-140.
@article{9d0d17b7030644cc9c8768d587a8fb33,
title = "Prevention of diabetic nephropathy",
abstract = "Normalization of blood pressure-and use of an ACE inhibitor or AT 1- receptor blocker for patients with abnormal albumin or creatinine levels-can prevent or significantly slow the rate of progression toward end-stage renal disease.",
author = "Materson, {Barry J} and Preston, {Richard A}",
year = "1997",
month = "2",
day = "15",
language = "English",
volume = "32",
pages = "129--140",
journal = "Hospital practice (1995)",
issn = "2154-8331",
publisher = "Taylor and Francis Ltd.",
number = "2",

}

TY - JOUR

T1 - Prevention of diabetic nephropathy

AU - Materson, Barry J

AU - Preston, Richard A

PY - 1997/2/15

Y1 - 1997/2/15

N2 - Normalization of blood pressure-and use of an ACE inhibitor or AT 1- receptor blocker for patients with abnormal albumin or creatinine levels-can prevent or significantly slow the rate of progression toward end-stage renal disease.

AB - Normalization of blood pressure-and use of an ACE inhibitor or AT 1- receptor blocker for patients with abnormal albumin or creatinine levels-can prevent or significantly slow the rate of progression toward end-stage renal disease.

UR - http://www.scopus.com/inward/record.url?scp=0031056919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031056919&partnerID=8YFLogxK

M3 - Article

C2 - 9040425

AN - SCOPUS:0031056919

VL - 32

SP - 129

EP - 140

JO - Hospital practice (1995)

JF - Hospital practice (1995)

SN - 2154-8331

IS - 2

ER -